Shiva Kazempour Dehkordi

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 8

Top Topics

High Performance Liquid Chromatography

Cognitive Decline

Top Venues

Research square

bioRxiv : the preprint server for biology

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Paulino Ramirez, Wenyan Sun, Shiva Kazempour Dehkordi, Habil Zare, Bernard Fongang, Kevin F Bieniek, Bess Frost
Nanopore-based DNA long-read sequencing analysis of the aged human brain. bioRxiv : the preprint server for biology (2024)
Paulino Ramirez, Wenyan Sun, Shiva Kazempour Dehkordi, Habil Zare, Bernard Fongang, Kevin F Bieniek, Bess Frost
Nanopore-based DNA long-read sequencing analysis of the aged human brain. bioRxiv : the preprint server for biology (2024)
Paulino Ramirez, Wenyan Sun, Shiva Kazempour Dehkordi, Habil Zare, Bernard Fongang, Kevin F Bieniek, Bess Frost
Nanopore-based DNA long-read sequencing analysis of the aged human brain. bioRxiv : the preprint server for biology (2024)
Miranda E Orr, Mitzi Gonzales, Valentina Garbarino, Tiffany Kautz, Juan Pablo Palavicini, Marisa Lopez-Cruzan, Shiva Kazempour Dehkordi, Julia Mathews, Habil Zare, Peng Xu, Bin Zhang, Crystal Franklin, Mohamad Habes, Suzanne Craft, Ronald C Petersen, Tamara Tchkonia, James L Kirkland, Arash Salardini, Sudha Seshadri, Nicolas Musi
Senolytic therapy to modulate the progression of Alzheimer's Disease (SToMP-AD) - Outcomes from the first clinical trial of senolytic therapy for Alzheimer's disease. Research square (2023)
Miranda E Orr, Mitzi Gonzales, Valentina Garbarino, Tiffany Kautz, Juan Pablo Palavicini, Marisa Lopez-Cruzan, Shiva Kazempour Dehkordi, Julia Mathews, Habil Zare, Peng Xu, Bin Zhang, Crystal Franklin, Mohamad Habes, Suzanne Craft, Ronald C Petersen, Tamara Tchkonia, James L Kirkland, Arash Salardini, Sudha Seshadri, Nicolas Musi
Senolytic therapy to modulate the progression of Alzheimer's Disease (SToMP-AD) - Outcomes from the first clinical trial of senolytic therapy for Alzheimer's disease. Research square (2023)
Miranda E Orr, Mitzi Gonzales, Valentina Garbarino, Tiffany Kautz, Juan Pablo Palavicini, Marisa Lopez-Cruzan, Shiva Kazempour Dehkordi, Julia Mathews, Habil Zare, Peng Xu, Bin Zhang, Crystal Franklin, Mohamad Habes, Suzanne Craft, Ronald C Petersen, Tamara Tchkonia, James L Kirkland, Arash Salardini, Sudha Seshadri, Nicolas Musi
Senolytic therapy to modulate the progression of Alzheimer's Disease (SToMP-AD) - Outcomes from the first clinical trial of senolytic therapy for Alzheimer's disease. Research square (2023)
Mitzi M Gonzales, Valentina R Garbarino, Tiffany F Kautz, Juan Pablo Palavicini, Marisa Lopez-Cruzan, Shiva Kazempour Dehkordi, Julia J Mathews, Habil Zare, Peng Xu, Bin Zhang, Crystal Franklin, Mohamad Habes, Suzanne Craft, Ronald C Petersen, Tamara Tchkonia, James L Kirkland, Arash Salardini, Sudha Seshadri, Nicolas Musi, Miranda E Orr
Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial. Nature medicine (2023)
Miranda E Orr, Mitzi Gonzales, Valentina Garbarino, Tiffany Kautz, Juan Pablo Palavicini, Marisa Lopez-Cruzan, Shiva Kazempour Dehkordi, Julia Mathews, Habil Zare, Peng Xu, Bin Zhang, Crystal Franklin, Mohamad Habes, Suzanne Craft, Ronald C Petersen, Tamara Tchkonia, James L Kirkland, Arash Salardini, Sudha Seshadri, Nicolas Musi
Senolytic therapy to modulate the progression of Alzheimer's Disease (SToMP-AD) - Outcomes from the first clinical trial of senolytic therapy for Alzheimer's disease. Research square (2023)